Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D05WTT
|
|||
| Former ID |
DIB006368
|
|||
| Drug Name |
Remune
|
|||
| Synonyms |
Salk Immunogen; AG-1661; IR-8101; RG-83894; SALK HIV-1 immunogen; Vaccine (HIV), IRC/Agouron/Trinity
Click to Show/Hide
|
|||
| Indication | Hereditary angioedema [ICD-11: 4A00.14; ICD-9: 277.6] | Phase 3 | [1] | |
| Human immunodeficiency virus infection [ICD-11: 1C62; ICD-9: 42] | Phase 2 | [2] | ||
| Human immunodeficiency virus-1 infection [ICD-11: 1C62; ICD-10: B20-B24] | Application submitted | [3], [4] | ||
| Company |
Immune response biopharma
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00005002) Effectiveness of Treating HIV-Positive Patients With an HIV Vaccine (Remune). U.S. National Institutes of Health. | |||
| REF 2 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
| REF 3 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
| REF 4 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.